Anonymous
Guest
Anonymous
Guest
That's what I hear from them and the numbers should be a lot better than this.
Aaaaahhhh....clueless retail rep making comments about something they know nothing about. Funny... in addition to all the hospital politics etc. about a new antibiotic, how about collateral damage? That is the main reason this drug is restricted to ID and will continue to be. I love all the talk about "lifting restrictions". What a joke. Will never happen. And how about the institutional ISTs? A joke. They are the most expendable in this company. Time to get rid of them and save each region 300k a year. (2 ISTs per region)